Clinical Trial Update: Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) [Phase 3]

View source ↗

Summary

Phase III clinical trial of a candidate PCV13 vaccine in healthy individuals aged 6 weeks and above has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Pneumococcal Infections
• Streptococcal Infections

Drugs mentioned

• PCV13 candidate vaccine (PICTPCV13i)

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Pneumococcal Infections, Streptococcal Infections | Phase 3 | Status: COMPLETED